0.92 USD
▲+0.01+1.05%
盘后 1.00 0.00%
2026-09-16
市值
$3.66M
市盈率
—
EPS
-8.31
股息率
—
52 周区间
0.88 – 6.76
成交量
14.61K
Beta
-0.14
目标价
17.75
52W 低 0.8852W 高 6.76
价格走势
公司简介
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the...